Esophageal stenosis after chemotherapy for breast cancer: A case report.


Journal

Medicine
ISSN: 1536-5964
Titre abrégé: Medicine (Baltimore)
Pays: United States
ID NLM: 2985248R

Informations de publication

Date de publication:
18 Mar 2022
Historique:
received: 26 01 2022
accepted: 23 02 2022
entrez: 31 3 2022
pubmed: 1 4 2022
medline: 7 4 2022
Statut: ppublish

Résumé

Esophageal stenosis after chemotherapy in breast cancer patients is rare. Distinguishing esophageal stenosis from esophageal metastasis caused by breast cancer is important. A 62-year-old woman diagnosed with advanced breast cancer and no distant metastases gradually developed skin changes, oral ulcers and mucosal injures after four cycles of chemotherapy. Dysphagia was the most severe symptom that greatly affected the patient's quality of life. Ultimately, esophageal stenosis and ulceration were confirmed by serial radiological examinations and endoscopic biopsy. Due to difficulties in eating orally, the patient was initially placed on a nasogastric tube in order to improve her nutritional status. Simultaneously, she was administered powerful proton pump inhibitors. She underwent modified radical mastectomy for breast cancer after her nutritional status improved. However, the patient was still suffering from severe dysphagia after more than 4 months of follow-up. Subsequently, she underwent removable esophageal stent implantation after after unsuccessful attempts to dilate her esophagus. The dysphagia symptoms were immediately alleviated to a certain degree, and the dilated cavity of the upper esophagus showed slight retraction. Esophageal stenosis is very infrequent in patients with breast cancer after chemotherapy. It needs to be. distinguished from esophageal metastasis caused by breast cancer. Esophageal stent implantation may provide benefits in terms of both symptom control and survival in patients with severe esophageal structures.

Identifiants

pubmed: 35356916
doi: 10.1097/MD.0000000000029045
pii: 00005792-202203180-00019
pmc: PMC10513326
pii:
doi:

Types de publication

Case Reports Journal Article

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

Copyright © 2022 the Author(s). Published by Wolters Kluwer Health, Inc.

Déclaration de conflit d'intérêts

The authors have no conflicts of interest to disclose.

Références

J Drugs Dermatol. 2009 Jan;8(1):61-4
pubmed: 19180897
Gland Surg. 2020 Apr;9(2):417-422
pubmed: 32420267
Lancet Oncol. 2014 Jun;15(7):e279-89
pubmed: 24872111
Gland Surg. 2021 Jan;10(1):252-261
pubmed: 33633981
Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2008 Aug;106(2):217-26
pubmed: 18554960
Cost Eff Resour Alloc. 2021 Feb 23;19(1):11
pubmed: 33622356
Gan To Kagaku Ryoho. 2020 Nov;47(11):1605-1608
pubmed: 33268737
Clin Gastroenterol Hepatol. 2017 Nov;15(11):A33-A34
pubmed: 28428102
J Coll Physicians Surg Pak. 2010 Nov;20(11):748-52
pubmed: 21078249

Auteurs

Zhen-Fei Ou (ZF)

Department of General Medicine, the Affiliated Hospital of Qingdao University, Qingdao, China,Department of Gastroenterology, the Affiliated Hospital of Qingdao University, Qingdao, China.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH